Please assess the completion status of the following clinical trial:

Trial Title: Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Girls, with Turner syndrome or ISS; height standard deviation score (SDS) ≤ -2~* Bone age ≤ 12 years~* Normal birthweight~* Body mass index (BMI) = 10th-90th percentile~* Normal childhood activity; no physical or other limitations~* Normal, balanced diet (20-40% calories from fat)~Exclusion Criteria:~* Puberty (beyond Tanner Stage 1)~* Diabetes in subject or first degree relative~* Sex steroid therapy~* Chronic conditions requiring medication (treatment for hypothyroidism is permissible)~* Significant systemic disease (pulmonary, cardiac, renal, or other)~* Non-removable metal

- Gender: FEMALE
- Minimum Age: 7 Years
- Maximum Age: 14 Years
- Healthy Volunteers: f

Study Arms:
- Turner syndrome (Type: None): Girls, aged 7-14, with short stature due to Turner syndrome and eligible for growth hormone therapy
- Control / idiopathic short stature (Type: None): Girls, aged 7-14, with idiopathic short stature and eligible for growth hormone therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).